Announcements Trials
Browse Landscape

Phase

Phase 2 3Phase 1/2 2Phase 1 2

Status

Completed 2Terminated 1

Sponsor Class

OTHER 3INDUSTRY 2NIH 1

Study Type

Interventional 3

Sponsor

Cancer Type

Sarcoma 2CNS 2

Conditions

Sarcoma 1Gliosarcoma 1Glioblastoma 1Central Nervous System Neoplasms 1Brain Neoplasms 1

Interventions

Cisplatin 1041Cyclophosphamide 973Carboplatin 954Radiotherapy 893Bevacizumab 847Gemcitabine 817pembrolizumab 759Paclitaxel 738Docetaxel 734Oxaliplatin 706Capecitabine 649Fluorouracil 564Rituximab 559Nivolumab 506Dexamethasone 487Etoposide 468Doxorubicin 458Irinotecan 442Drug Therapy 402Leucovorin 377Cytarabine 342Cetuximab 340Lenalidomide 326Trastuzumab 323Pemetrexed 315durvalumab 295Filgrastim 287Magnetic Resonance Spectroscopy 278Temozolomide 275Prednisone 274

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 2 × OTHER × vitespin × Clear all
NCT01814813 2025-01-24

Vaccine Therapy With Bevacizumab Versus Bevacizumab Alone in Treating Patients With Recurrent Glioblastoma Multiforme That Can Be Removed by Surgery

Alliance for Clinical Trials in Oncology

Phase 2 Terminated
90 enrolled 13 charts
CNSSarcoma

Brain Neoplasms, Glioblastoma, Gliosarcoma

NCT00905060 2021-03-24

HeatShock

University of California, San Francisco

Phase 2 Completed
70 enrolled 12 charts
CNS

Central Nervous System Neoplasms

NCT00005628 2013-06-19

Vaccine Therapy in Treating Patients With Recurrent Soft Tissue Sarcoma

Memorial Sloan Kettering Cancer Center

Phase 2 Completed
Sarcoma

Sarcoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡